McKean-Cowdin R - Search Results

1

Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.

Dowty JG, Lee E, McKean-Cowdin R, Henderson BE, Bernstein L, Ursin G, Hopper JL. Dowty JG, et al. Breast Cancer Res Treat. 2014 Feb;144(1):171-7. doi: 10.1007/s10549-014-2845-6. Epub 2014 Jan 31. Breast Cancer Res Treat. 2014. PMID: 24481681 Free PMC article.

2

Refractive Error and Anterior Chamber Depth as Risk Factors in Primary Angle Closure Disease: The Chinese American Eye Study.

Zhou S, Pardeshi AA, Burkemper B, Apolo G, Cho A, Jiang X, Torres M, McKean-Cowdin R, Varma R, Xu BY. Zhou S, et al. Among authors: mckean cowdin r. J Glaucoma. 2023 Apr 1;32(4):257-264. doi: 10.1097/IJG.0000000000002154. Epub 2023 Feb 22. J Glaucoma. 2023. PMID: 36847699 Free PMC article.

3

Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.

Feigelson HS, McKean-Cowdin R, Pike MC, Coetzee GA, Kolonel LN, Nomura AM, Le Marchand L, Henderson BE. Feigelson HS, et al. Cancer Res. 1999 Aug 15;59(16):3908-10. Cancer Res. 1999. PMID: 10463580

4

Declining cancer rates in the 1990s.

McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. McKean-Cowdin R, et al. J Clin Oncol. 2000 Jun;18(11):2258-68. doi: 10.1200/JCO.2000.18.11.2258. J Clin Oncol. 2000. PMID: 10829046

5

Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight.

Probst-Hensch NM, Pike MC, McKean-Cowdin R, Stanczyk FZ, Kolonel LN, Henderson BE. Probst-Hensch NM, et al. Br J Cancer. 2000 Jun;82(11):1867-70. doi: 10.1054/bjoc.1999.1082. Br J Cancer. 2000. PMID: 10839304 Free PMC article.

6

Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates.

Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE. Feigelson HS, et al. Cancer Res. 2001 Jan 15;61(2):785-9. Cancer Res. 2001. PMID: 11212283 Free article.

7

Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype.

McKean-Cowdin R, Feigelson HS, Pike MC, Coetzee GA, Kolonel LN, Henderson BE. McKean-Cowdin R, et al. Cancer Res. 2001 Feb 1;61(3):848-9. Cancer Res. 2001. PMID: 11221867

8

Germ-line HER-2 variant and breast cancer risk by stage of disease.

McKean-Cowdin R, Kolonel LN, Press MF, Pike MC, Henderson BE. McKean-Cowdin R, et al. Cancer Res. 2001 Dec 1;61(23):8393-4. Cancer Res. 2001. PMID: 11731415

9

Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

Feigelson HS, McKean-Cowdin R, Henderson BE. Feigelson HS, et al. Mutagenesis. 2002 Sep;17(5):445-6; author reply 447-8. doi: 10.1093/mutage/17.5.445. Mutagenesis. 2002. PMID: 12202634 No abstract available.

10

IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort.

DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F, Probst-Hensch NM. DeLellis K, et al. Br J Cancer. 2003 Jan 27;88(2):277-82. doi: 10.1038/sj.bjc.6600728. Br J Cancer. 2003. PMID: 12610514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters